ASX-listed biotechnology companies
Since AusBiotech was founded in 1985, the industry has grown from a mere handful of companies to have an ASX-listed market capitalisation of more than $252 billion in 178 companies (March 2024 AusBioStocks), with a further 1,231+ private companies creating value. The market cap is one quantifiable measure of the life science sector’s economic contribution to the Australian economy, and the proportion of biotech companies achieving market valuations greater than $100 million measures the industry’s ability to create companies of significant future value.
Below is a listing of the ASX-listed companies; data is delayed by at least 20 minutes. Click on a company name to find find out more about them. Company information is updated every six months to include newly-listed and delisted companies.
Service provided by WebLink.